Cobb Stuart 4
4 · Neurogene Inc. · Filed Mar 14, 2024
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Cobb Stuart
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-03-13+20,391→ 20,391 total - Award
Stock Option (Right to Buy)
2024-03-13+34,450→ 34,450 totalExercise: $36.06Exp: 2034-03-13→ Common Stock (34,450 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.